Recent Security Class Actions

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ: TLX)

Company Name:Telix Pharmaceuticals Limited American Depositary Shares
Stock Symbol:NASDAQ: TLX
Class Period Start:02/21/2025
Class Period End (inclusive):08/28/2025
Filing Deadline:01/09/2026

The complaint alleges defendants made false and/or misleading statements and/or failed to disclose that: (1); Defendants materially overstated the progress Telix had made with regard to prostate cancer therapeutic candidates; (2) Defendants materially overstated the quality of Telix’s supply chain and partners; and (3) as a result, Defendants’ statements about Telix’s business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.